Jatt Acquisition Corp Cl A (JATT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JATT | AMGN | REGN | VRTX | GILD |
| Company | Jatt Acquisition Corp Cl A | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 10.38 | 318.72 | 1,015.40 | 454.98 | 84.34 |
| High | 10.51 | 320.74 | 1,023.09 | 458.14 | 84.96 |
| Low | 7.80 | 316.43 | 1,007.28 | 452.62 | 83.98 |
| Last | 8.16 | 319.66 | 1,012.82 | 455.31 | 84.59 |
| Change | -2.59 | +2.18 | -1.77 | +1.76 | +0.42 |
| % Change | -24.09% | +0.69% | -0.17% | +0.39% | +0.50% |
| Volume | 88,500 | 1,467,800 | 1,071,700 | 781,700 | 4,054,300 |
| 20-Day Average Volume | 46,075 | 2,096,945 | 689,055 | 966,380 | 7,713,830 |
| Previous Close | 10.75 | 317.48 | 1,014.59 | 453.55 | 84.17 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.22 | 327.11 | 1,094.59 | 469.25 | 83.17 |
| 20-Day Raw Stochastic | 7.86% | 27.77% | 3.39% | 8.05% | 88.18% |
| 20-Day Relative Strength | 27.48% | 45.19% | 31.95% | 40.75% | 67.32% |
| Weighted Alpha | -20.21 | +18.06 | +16.09 | +21.44 | +19.44 |
| Today's Opinion | 8% Buy | 24% Buy | 8% Buy | 8% Buy | 88% Buy |
| Previous Opinion | 100% Buy | 24% Buy | 8% Buy | 8% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 64% Buy | 80% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.11% since 03/13/23 | -0.93% since 09/27/24 | -2.86% since 09/27/24 | -1.64% since 09/27/24 | +1.17% since 09/27/24 |
| Low | 7.80 on 03/20/23 | 315.46 on 10/03/24 | 1,007.28 on 10/04/24 | 452.26 on 10/03/24 | 82.82 on 10/01/24 |
| High | 12.38 on 03/16/23 | 323.23 on 09/30/24 | 1,061.60 on 10/01/24 | 472.31 on 10/01/24 | 85.43 on 10/02/24 |
| 1-Month | |||||
| %Chg | -21.91% since 02/15/23 | -3.32% since 09/04/24 | -14.12% since 09/04/24 | -4.86% since 09/04/24 | +6.90% since 09/04/24 |
| Low | 7.80 on 03/20/23 | 312.16 on 09/25/24 | 1,007.28 on 10/04/24 | 452.26 on 10/03/24 | 77.74 on 09/05/24 |
| High | 12.38 on 03/16/23 | 339.17 on 09/23/24 | 1,175.16 on 09/05/24 | 490.15 on 09/16/24 | 85.43 on 10/02/24 |
| 3-Month | |||||
| %Chg | -20.00% since 12/13/22 | +3.32% since 07/03/24 | -1.10% since 07/03/24 | -3.18% since 07/03/24 | +27.03% since 07/03/24 |
| Low | 7.80 on 03/20/23 | 306.59 on 08/07/24 | 1,007.28 on 10/04/24 | 452.26 on 10/03/24 | 66.01 on 07/05/24 |
| High | 12.38 on 03/16/23 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 85.43 on 10/02/24 |
| 6-Month | |||||
| %Chg | -18.73% since 09/20/22 | +19.24% since 04/04/24 | +8.09% since 04/04/24 | +12.70% since 04/04/24 | +21.62% since 04/04/24 |
| Low | 7.80 on 03/20/23 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 12.38 on 03/16/23 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 85.43 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 140,760 | 171,476,816 | 111,598,568 | 117,494,112 | 105,386,704 |
| Shares Outstanding, K | 17,250 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 6,850,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | 458,470 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 0.00 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/14/22 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | N/A | 10/30/24 | 10/31/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.07 | 26.41 | 0.00 | 17.91 |